Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nutriband Inc. (NTRB:NASDAQ), powered by AI.
Nutriband Inc. is currently trading at $3.31. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nutriband Inc. on Alpha Lenz.
Nutriband Inc.'s P/E ratio is -4.7.
“Nutriband Inc. trades at a P/E of -4.7 (undervalued) with modest ROE of -125.6%.”
Ask for details →Nutriband Inc. is a pharmaceutical and healthcare company specializing in the development and commercialization of transdermal products and technologies. The primary focus of Nutriband is to improve the safety and efficacy of drug delivery systems. By leveraging transdermal adhesive materials, Nutriband Inc. offers an innovative approach to drug administration that bypasses the gastrointestinal tract and liver, enabling a more direct and controlled delivery to the bloodstream. This approach can reduce side effects and improve patient compliance. Nutriband's technologies have broader applications not only in delivering medications effectively but also in enhancing safety in medical treatments, which is critical across pharmaceutical and biotechnology industries. With its commitment to therapeutic advancements, Nutriband Inc. plays an essential role in the ongoing transformation of drug delivery systems, potentially impacting a variety of treatment areas and improving patients' experiences across different healthcare settings.
“Nutriband Inc. trades at a P/E of -4.7 (undervalued) with modest ROE of -125.6%.”
Ask for details →Nutriband Inc. (ticker: NTRB) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). Market cap is $39M.
The current price is $3.31 with a P/E ratio of -4.68x and P/B of 5.77x.
ROE is -125.56% and operating margin is -408.41%. Annual revenue is $2M.